-
1
المؤلفون: Sijde, F. van der, Dik, W.A., Mustafa, D.A.M., Vietsch, E.E., Besselink, M.G., Debets, R., Koerkamp, B.G., Haberkorn, B.C.M., Homs, M.Y.V., Janssen, Q.P., Luelmo, S.A.C., Mekenkamp, L.J.M., Oostvogels, A.A.M., Nijenhuis, M.A.W.S.T., Wilmink, J.W., Eijck, C.H.J. van
المساهمون: Surgery, Immunology, Pathology, Medical Oncology, CCA - Cancer Treatment and Quality of Life, Amsterdam Gastroenterology Endocrinology Metabolism, Oncology, CCA - Cancer biology and immunology
المصدر: Frontiers in Immunology, 13:898498. Frontiers Media S.A.
Frontiers in immunology, 13:898498. Frontiers Media S.A.
Frontiers in Immunology, 13. FRONTIERS MEDIA SAمصطلحات موضوعية: Interleukin-7, pancreatic cancer, Immunology, Interleukin-18, Leucovorin, treatment response, Irinotecan, Oxaliplatin, Pancreatic Neoplasms, Interleukin 1 Receptor Antagonist Protein, IL-1RA, SDG 3 - Good Health and Well-being, Antineoplastic Combined Chemotherapy Protocols, cytokine, Cytokines, Humans, biomarker, Immunology and Allergy, Fluorouracil, Chemokine CCL4, Carcinoma, Pancreatic Ductal
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::493dbacff71760bbb74091a085213bbc
https://doi.org/10.3389/fimmu.2022.898498